A developing country response to Lavery <it>et al</it>. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?"
<p>Abstract</p> <p>Background</p> <p>A recent paper presents an argument and mechanism for the possible stopping of clinical trials early based on opportunity costs.</p> <p>Discussion</p> <p>Although we agree that the costs and opportunity costs...
Main Authors: | Wassenaar Douglas R, Ramjee Gita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | BMC Medical Ethics |
Online Access: | http://www.biomedcentral.com/1472-6939/10/16 |
Similar Items
-
In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?
by: James V Lavery, et al.
Published: (2009-06-01) -
Lavery’s Frozen: The Psychosexual History of a Sexual Predator and the Poetics of Anti-Paedophilia
by: Murat Öğütcü
Published: (2018-06-01) -
Les laveries de quartier à Paris : une pratique urbaine entre intimité et sociabilité
by: Nordier, Richard
Published: (2009) -
A DETAILED SEDIMENTOLOGICAL AND GEOMORPHOLOGICAL INVESTIGATION OF WISCONSINAN TILLS NEAR THE LAVERY TYPE SECTION, NORTHWEST PENNSYLVANIA
by: Weinrich, Matthew C.
Published: (2006) -
Accountability in clinical trial diversity: The buck stops where?
by: Lauren D. Nephew
Published: (2021-06-01)